DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $404,686 | -6.8% | 1,749 | 0.0% | 0.21% | -24.9% |
| Q3 2023 | $433,992 | -4.7% | 1,749 | -7.9% | 0.28% | +5.3% |
| Q2 2023 | $455,574 | -9.5% | 1,898 | -5.0% | 0.26% | -7.4% |
| Q1 2023 | $503,622 | -16.7% | 1,998 | -12.3% | 0.28% | -19.5% |
| Q4 2022 | $604,667 | -12.2% | 2,278 | -14.6% | 0.35% | -60.4% |
| Q3 2022 | $689,000 | +24.8% | 2,668 | +22.5% | 0.89% | +48.7% |
| Q2 2022 | $552,000 | -13.6% | 2,178 | 0.0% | 0.60% | +14.1% |
| Q1 2022 | $639,000 | -10.9% | 2,178 | 0.0% | 0.52% | +23.8% |
| Q4 2021 | $717,000 | +8.1% | 2,178 | 0.0% | 0.42% | +3.4% |
| Q3 2021 | $663,000 | +15.3% | 2,178 | +1.6% | 0.41% | +17.5% |
| Q2 2021 | $575,000 | +5.3% | 2,143 | -11.7% | 0.35% | -10.1% |
| Q1 2021 | $546,000 | +6.2% | 2,428 | +4.9% | 0.39% | -20.3% |
| Q4 2020 | $514,000 | +10.3% | 2,314 | +6.9% | 0.49% | +0.4% |
| Q3 2020 | $466,000 | +21.7% | 2,165 | 0.0% | 0.48% | +24.7% |
| Q2 2020 | $383,000 | +27.7% | 2,165 | 0.0% | 0.39% | +8.4% |
| Q1 2020 | $300,000 | – | 2,165 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |